Freestone Grove Partners’s Diebold Nixdorf DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
MCM
Freestone Grove Partners's DBD Position: Q2 2026 in Review
Freestone Grove Partners increased its Diebold Nixdorf (DBD) stake by 21% in Q2 2026, buying an estimated $117K and bringing the position to 8,275 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #593.
Freestone Grove Partners first reported a position in DBD in Q3 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.
- Freestone Grove Partners held 8,275 shares of Diebold Nixdorf worth $704K as of Q2 2026.
- Freestone Grove Partners bought 1,459 Diebold Nixdorf shares in Q2 2026, an estimated $117K.
- Diebold Nixdorf made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #593 holding.
- Freestone Grove Partners first reported a position in Diebold Nixdorf in Q3 2025 and has held it in 3 quarters since.
- 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.